209 related articles for article (PubMed ID: 22213727)
21. Vertebral fractures and increased sensitivity to corticosteroids in a child with ulcerative colitis: successful use of pamidronate.
Lucarelli S; Borrelli O; Paganelli M; Capocaccia P; Frediani T; Ferri F; Cucchiara S
J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):533-5. PubMed ID: 17033531
[No Abstract] [Full Text] [Related]
22. High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy.
Alos N; Grant RM; Ramsay T; Halton J; Cummings EA; Miettunen PM; Abish S; Atkinson S; Barr R; Cabral DA; Cairney E; Couch R; Dix DB; Fernandez CV; Hay J; Israels S; Laverdière C; Lentle B; Lewis V; Matzinger M; Rodd C; Shenouda N; Stein R; Stephure D; Taback S; Wilson B; Williams K; Rauch F; Siminoski K; Ward LM
J Clin Oncol; 2012 Aug; 30(22):2760-7. PubMed ID: 22734031
[TBL] [Abstract][Full Text] [Related]
23. The use of intravenous bisphosphonate therapy to treat vertebral fractures due to osteoporosis among boys with Duchenne muscular dystrophy.
Sbrocchi AM; Rauch F; Jacob P; McCormick A; McMillan HJ; Matzinger MA; Ward LM
Osteoporos Int; 2012 Nov; 23(11):2703-11. PubMed ID: 22297733
[TBL] [Abstract][Full Text] [Related]
24. Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.
Zhang Y; Milojevic D
Paediatr Drugs; 2017 Jun; 19(3):193-211. PubMed ID: 28290112
[TBL] [Abstract][Full Text] [Related]
25. Notable difference between the development of vertebral fracture and osteonecrosis of the femoral head in patients treated with high-dose glucocorticoids for systemic rheumatic diseases.
Kameda H; Amano K; Nagasawa H; Ogawa H; Sekiguchi N; Takei H; Suzuki K; Takeuchi T
Intern Med; 2009; 48(22):1931-8. PubMed ID: 19915292
[TBL] [Abstract][Full Text] [Related]
26. Prevalent vertebral fractures and minor vertebral deformities analyzed by vertebral fracture assessment (VFA) increases the risk of incident fractures in postmenopausal women: the FRODOS study.
Kanterewicz E; Puigoriol E; Rodríguez Cros JR; Peris P
Osteoporos Int; 2019 Oct; 30(10):2141-2149. PubMed ID: 31123788
[TBL] [Abstract][Full Text] [Related]
27. Quantitative computed tomography discriminates between postmenopausal women with low spine bone mineral density with vertebral fractures and those with low spine bone mineral density only: the SHATTER study.
Paggiosi MA; Debono M; Walsh JS; Peel NFA; Eastell R
Osteoporos Int; 2020 Apr; 31(4):667-675. PubMed ID: 31993717
[TBL] [Abstract][Full Text] [Related]
28. Bone health and growth in glucocorticoid-treated patients with juvenile idiopathic arthritis.
Valta H; Lahdenne P; Jalanko H; Aalto K; Mäkitie O
J Rheumatol; 2007 Apr; 34(4):831-6. PubMed ID: 17309121
[TBL] [Abstract][Full Text] [Related]
29. Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density.
Hayashi K; Yamamoto M; Murakawa Y; Yamauchi M; Kaji H; Yamaguchi T; Sugimoto T
Osteoporos Int; 2009 Nov; 20(11):1889-94. PubMed ID: 19387764
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticoid-related changes in body mass index among children and adolescents with rheumatic diseases.
Shiff NJ; Brant R; Guzman J; Cabral DA; Huber AM; Miettunen P; Roth J; Scuccimarri R; Alos N; Atkinson SA; Collet JP; Couch R; Cummings EA; Dent PB; Ellsworth J; Hay J; Houghton K; Jurencak R; Lang B; Larche M; Leblanc C; Rodd C; Saint-Cyr C; Stein R; Stephure D; Taback S; Rauch F; Ward LM;
Arthritis Care Res (Hoboken); 2013 Jan; 65(1):113-21. PubMed ID: 22826190
[TBL] [Abstract][Full Text] [Related]
31. Ibandronate treatment reverses glucocorticoid-induced loss of bone mineral density and strength in minipigs.
Glüer CC; Scholz-Ahrens KE; Helfenstein A; Delling G; Timm W; Açil Y; Barkmann R; Hassenpflug J; Stampa B; Bauss F; Schrezenmeir J
Bone; 2007 Mar; 40(3):645-55. PubMed ID: 17174621
[TBL] [Abstract][Full Text] [Related]
32. Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease.
Benchimol EI; Ward LM; Gallagher JC; Rauch F; Barrowman N; Warren J; Beedle S; Mack DR
J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):538-45. PubMed ID: 18030230
[TBL] [Abstract][Full Text] [Related]
33. Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials.
Amiche MA; Albaum JM; Tadrous M; Pechlivanoglou P; Lévesque LE; Adachi JD; Cadarette SM
Osteoporos Int; 2016 May; 27(5):1709-18. PubMed ID: 26694595
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of vertebral compression fractures and associated factors in children and adolescents with severe juvenile idiopathic arthritis.
Markula-Patjas KP; Valta HL; Kerttula LI; Soini IH; Honkanen VE; Toiviainen-Salo SM; Mäkitie OM
J Rheumatol; 2012 Feb; 39(2):365-73. PubMed ID: 22133619
[TBL] [Abstract][Full Text] [Related]
35. Trabecular bone score improves fracture risk assessment in glucocorticoid-induced osteoporosis.
Florez H; Hernández-Rodríguez J; Muxi A; Carrasco JL; Prieto-González S; Cid MC; Espinosa G; Gómez-Puerta JA; Monegal A; Guañabens N; Peris P
Rheumatology (Oxford); 2020 Jul; 59(7):1574-1580. PubMed ID: 31628810
[TBL] [Abstract][Full Text] [Related]
36. Vertebral fracture risk in glucocorticoid-induced osteoporosis: the role of hypogonadism and corticosteroid boluses.
Florez H; Hernández-Rodríguez J; Carrasco JL; Prieto-González S; Muxi A; Filella X; Ruiz-Gaspà S; Gómez-Puerta JA; Cid M; Espinosa G; Monegal A; Guañabens N; Peris P
RMD Open; 2020 Sep; 6(2):. PubMed ID: 32917834
[TBL] [Abstract][Full Text] [Related]
37. Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial.
Glüer CC; Marin F; Ringe JD; Hawkins F; Möricke R; Papaioannu N; Farahmand P; Minisola S; Martínez G; Nolla JM; Niedhart C; Guañabens N; Nuti R; Martín-Mola E; Thomasius F; Kapetanos G; Peña J; Graeff C; Petto H; Sanz B; Reisinger A; Zysset PK
J Bone Miner Res; 2013 Jun; 28(6):1355-68. PubMed ID: 23322362
[TBL] [Abstract][Full Text] [Related]
38. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
Van Staa TP; Laan RF; Barton IP; Cohen S; Reid DM; Cooper C
Arthritis Rheum; 2003 Nov; 48(11):3224-9. PubMed ID: 14613287
[TBL] [Abstract][Full Text] [Related]
39. Ibandronate increases cortical bone density in patients with systemic lupus erythematosus on long-term glucocorticoid.
Li EK; Zhu TY; Hung VY; Kwok AW; Lee VW; Lee KK; Griffith JF; Li M; Wong KC; Leung PC; Qin L; Tam LS
Arthritis Res Ther; 2010; 12(5):R198. PubMed ID: 20964867
[TBL] [Abstract][Full Text] [Related]
40. The choice of normative pediatric reference database changes spine bone mineral density Z-scores but not the relationship between bone mineral density and prevalent vertebral fractures.
Ma J; Siminoski K; Alos N; Halton J; Ho J; Lentle B; Matzinger M; Shenouda N; Atkinson S; Barr R; Cabral DA; Couch R; Cummings EA; Fernandez CV; Grant RM; Rodd C; Sbrocchi AM; Scharke M; Rauch F; Ward LM;
J Clin Endocrinol Metab; 2015 Mar; 100(3):1018-27. PubMed ID: 25494661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
